Technology Digest Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Digest Bermuda.

Press releases published on October 6, 2026

Virtune AB (Publ) lanseeraa Virtune Zcash ETP:n Nasdaq Stockholmissa
Virtune AB (Publ) lanserar Virtune Zcash ETP på Nasdaq Stockholm
Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
Minerva Humanoids Emerges From Stealth With $10M Pre-Seed Round Led by General Catalyst to Build Humanoid Robots for the World's Most Dangerous Jobs
Zscaler Hosts 2026 Investor Day, Reaffirms First Quarter and Fiscal 2027 Guidance
Applied Digital Secures Up to 1 GW of Potential Power Capacity in Finland, Marking First International Development in the Nordics
MediciNova to Participate in the Maxim Growth Summit
PathMaker Neurosystems Announces Publication of First-Ever Study Showing Non-Invasive Clearance of Toxic TDP-43 Protein Aggregates in Preclinical ALS Study
Roadzen to Present at Maxim Growth Summit and ThinkEquity Conference
Much more than promotion in construction: 12Build supports subcontractors through the entire bidding process
Veel meer dan promotie in de bouw: 12Build ondersteunt bouwspecialisten in het héle biedingsproces
Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026
Caseware Verity-Powered Risk Suggestion Agent Launches to Help Auditors Identify Engagement-Specific Risks
RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01
Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program
RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia
One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event
LUBIS EDA Launches FormalOS: Infrastructure for Systematic, Scalable Formal Verification

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology Digest Bermuda

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.